 controversy. Although third-party payers often require a
trial of compression stockings, there is virtually no scientific
evidence to support such a policy when saphenous ablation
to treat superficial reflux is both more efficacious and

JOURNAL OF VASCULAR SURGERY
May Supplement 2011

20S Gloviczki et al

cost-effective, a fact supported by data of the REACTIV
trial. In addition, some patients, such